Skip to content

The median effective dose of cypofol in inhibition of double-cavity tracheal intubation response induced by combined sufentanil: a dose-exploration study

The median effective dose of cypofol in inhibition of double-cavity tracheal intubation response induced by combined sufentanil: a dose-exploration study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078707
Enrollment
Unknown
Registered
2023-12-15
Start date
2023-12-20
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular responses to tracheal intubation

Interventions

Older age group:The initial infusion dose of cyclopofol was 0.3mg/kg in the elderly group and pumped at a rate of 200ml/h. If the patient s tracheal intubation response was positive, the next patient
Non-elderly group:The initial infusion dose of cypofol was 0.4mg/kg in the non-elderly group and pumped at a rate of 200ml/h. If the patient s tracheal intubation response was positive, the next patie

Sponsors

Henan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1) Age =18 years, =89 years; 2) General anesthesia double-cavity tracheal intubation was performed at selected time; 3)ASA grade I-III; 4) Voluntarily sign informed consent;

Exclusion criteria

Exclusion criteria: 1) Previous history of poor anesthesia, such as anesthesia allergy or malignant hyperthermia; 2) cyclopofol allergy; 3) Body mass index is too high or too low, such as IBM > 30kg/m2 or 120 times/min or HR < 60 times/min); 6) Apnea, history of difficulty intubation, or preoperative evaluation of suspicious difficult airway; 7) High risk of reflux aspiration; 8) Severe abnormal liver and kidney function (Child-PughC grade, preoperative dialysis); 9) Communication barriers, inability to cooperate, such as language comprehension disorders, mental illness, etc.; 10) History of drug use or drug abuse; 11) Hypertension that was difficult to control before surgery, and SBP=180mmHg or/and DBP=110mmHg; 12) Refusal to participate in the experiment;

Design outcomes

Primary

MeasureTime frame
Blood pressure;Heart rate;

Secondary

MeasureTime frame
Bispectral index;Cyclopofol dosage;Adverse reaction;

Countries

China

Contacts

Public ContactJiaqiang Zhang

Henan Provincial People's Hospital

jiaqiang197628@163.com+86 139 3712 1360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026